28 Jun 2022 MRM Health starts clinical trial with next-generation optimized consortium therapeutic MH002 in Pouchitis Member news
28 Jun 2022 Confo Therapeutics awarded EUR 1.7M VLAIO grant to expand application of ConfoBody® drug discovery and development technology in rare diseases Member news
24 Jun 2022 argenx receives positive CHMP opinion for efgartigimod for the treatment of adult patients with generalized myasthenia gravis in Europe Member news
24 Jun 2022 ImmuneWatch signs licence agreement with UAntwerp and UZA and officially becomes a university spin-off company Member news
23 Jun 2022 Fujirebio acquires ADx NeuroSciences and confirms its intentions to bring better and earlier neurodegenerative disease diagnostic solutions to the global diagnostics industry Member news
23 Jun 2022 Charles River and Ziphius Vaccines collaborate to manufacture saRNA-based vaccine Member news
22 Jun 2022 Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies Member news
22 Jun 2022 Biocartis announces new agreement with AstraZeneca for the development and marketing of a companion diagnostic test for Tagrisso® Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
